SEC Form 3/A · accession 0001144204-15-041405

VACCINOGEN INC · VGEN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

This is an amendment (Form 3/A). It replaces an earlier filing for the same period.

Reporting owners

Officer — Chairman and CEO · Director · 10% Owner

10% Owner

Period of report

Sep 3, 2013

Accepted (ET)

Jul 7, 2015 · 5:18 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001453001

Table I — non-derivative securities

Security	Date	Code	Shares	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	holding	—	—	—	218,179	D
Common Stock^F1,F3	holding	—	—	—	3,423,839	I	Ownership by Hanna Enterprises, LLC
Common Stock^F1,F4	holding	—	—	—	23,188	I	Ownership by Intracel Holding Corporation

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Warrant (right to buy)^F1,F2	$1.00	holding	—	—	—	Jun 2, 2008	Feb 28, 2015	Common Stock	200,000	—	D

F1This amended Form 3 is being filed to (a) include Hanna Enterprises, LLC (the "LLC") as a 10% owner of issuer securities, (b) remove 84,083 shares reported in the prior Form 3 as owned by Dr. Michael G. Hanna, Jr., and (c) correct and clarify the ownership form of the securities owned by the LLC and Dr. Hanna. The ownership and other information reflected in this amended Form 3 is as of its original filing date (September 3, 2013).
F2These securities are owned directly by Dr. Hanna.
F3These securities are owned directly by the LLC, a 10% owner of the issuer, and indirectly by Dr. Hanna as a member and general manager of the LLC. Dr. Hanna is an officer, director and 10% owner of the issuer. Dr. Hanna disclaims beneficial ownership of these reported securities except to the extent of his pecuniary interest therein.
F4These securities are owned directly by Intracel Holding Corporation ("Intracel") and indirectly by Dr. Hanna, as an owner of Intracel.